XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Choosing between cash back and points for travel can impact your rewards. Explore which option suits your travel style!
27,012 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
As AeroVironment approaches its March earnings release, a growing chorus of analysts signals meaningful upside, point...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Tim Cook discusses the moment he took the reins from Steve Jobs and the founder's advice to pursue the right path for...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Oil prices surged to a four-year high on supply shocks and geopolitical risk, signaling a volatile near term. This re...
Figma stock shows signs of a potential rebound as profitability improves and AI-driven features gain traction, even a...
Hive Digital Technologies stock rallied after a bold AI infrastructure plan caught investors' attention. This article...
A fresh stake in COPT Defense Properties signals a calculated tilt toward defense-related real estate. This article b...
The Trump administration faces a court-backed pause on universal tariff refunds, even as more than $20 billion has al...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
A fresh deal and growing demand for nuclear fuel have sparked a notable move in centrus energy group stock. This arti...